AntagomiR-22-3p injection alters miRNA expression and muscle fiber type of intrauterine growth restricted lambs

Authors: DUCKETT, SUSAN - Clemson University; GREENE, MASLYN - Clemson University; UDOKA, ALIUTE N. - Clemson University; WORLEY, GRAYSON - Clemson University; Klotz, James

Submitted to: American Society of Animal Science Annual Meeting
Publication Type: Abstract Only
Publication Acceptance Date: 4/11/2024
Publication Date: 9/18/2024
Citation: Duckett, S.K., Greene, M.A., Udoka, A.S., Worley, G., Klotz, J.L. 2024. AntagomiR-22-3p injection alters miRNA expression and muscle fiber type of intrauterine growth restricted lambs [abstract]. In: Journal of Animal Science. American Society of Animal Science Annual Meeting, Calgary, Canada, July 21-25, 2024. 102 S3:197-198

Interpretive Summary:

Technical Abstract: MicroRNAs (miRNA) are involved in regulating gene expression and muscle development. Previous research identified miR-22-3p as differentially regulated during muscle hypertrophy and in vitro experiments found that antagomir-22-3p enhanced satellite cell proliferation. The objective of this study was to test in vivo vascular injection of antagomir-22-3p in lateral saphenous vein on miRNA and HDAC family mRNA expression in intrauterine growth restricted lambs. Pregnant ewes (n = 18) with twins were either fed at 100% of NRC (CON) or nutrient restricted (60% NRC; NR) from gestational d 85 to parturition. On d 12 of age, NR lambs (n = 8) were randomly selected and given a systemic injection of antagomir-22-3p in the lateral saphenous vein of the right leg (MIR-NR). CON lambs (n =8) were also randomly selected and given a sham injection of PBS in the lateral saphenous vein of the right leg (SHAM-CON). Antagomir-22-3p was reconstituted in phosphate buffered saline (PBS). Injections were given for 3 consecutive days and lambs harvested 24 d later. Blood samples were collected from each lamb weekly to monitor miR-22-3p expression. Lambs were slaughtered 24 d after the first injection and muscle mass measured. Muscle samples were removed for miR-22-3p and mRNA expression of potential targets. Cell-free circulating RNA was isolated from blood samples and miR-22-3p expression examined over time. Cell-free circulating miR-22-3p expression was downregulated (P < 0.05) for MIR-NR compared to SHAM-CON on d 14 after injection. On d 21 after injection, miR-22-3p expression in plasma tended (P = 0.08) to be down-regulated in MIR-NR compared to SHAM-CON. Lamb body weight and muscle weights at harvest were similar between MIR-NR and SHAM-CON treatments. In heart and semimembranosus (SM) muscles, expression of miR-22-3p was down-regulated (P < 0.05) in MIR-NR compared to SHAM-CON. In the gastrocnemius and semitendinosus muscle, miR-22-3p expression was unchanged (P > 0.05). The number of type I and IIa muscle fibers were greater (P < 0.05) for MIR-NR than SHAM-CON. The number of type IIx fibers did not differ (P > 0.05). MIR-NR treatment appears to shift muscle fibers towards more oxidative metabolism and down-regulate HDAC-1, 3, and 11 and SIRT6 in SM. The systemic injection of antagomir-22-3p down-regulated miR-22-3p expression in circulation and in muscle tissues, which altered expression of HDAC/SIRT genes involved in muscle fiber type conversion and hypertrophy.